Tradestie Institutional Equity Comparison Engine

ABVC vs CNVS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CNVS Overall Edge

CNVS Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cineverse Corp. Class A Common Stock (CNVS) driven by superior Valuation, Momentum & Technical, Options & Structure while ABVC counters with relative strength in Growth & Margin. Fundamentally, ABVC trades at N/M Forward P/E with 0.0% operating margin (+104.5% YoY revenue) versus CNVS at 38.8x Forward P/E and -12.0% operating margin (+110.0% YoY). In options structure, ABVC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CNVS sits in UNCLASSIFIED (28th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CNVS
ABVC N/M vs CNVS 38.8x Fwd P/E
Growth & Margin Winner ABVC
Op Margin 0.0% vs -12.0% ยท YoY +104.5% vs +110.0%
Momentum & Technical Winner CNVS
1Y -68.2% vs -32.4% ยท 52W Pos 7% vs 16%
Options & Structure Winner CNVS
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (28th %ile IV)
ABVC NASDAQ
ABVC BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$0.87
-1.56% 1D
Market Cap $23.9M
1M Return -17.28%
1Y Return -68.15%
Forward P/E N/M
Unified AI Score
47.4 / 100 HOLD
Tech 43.0 Fund 50.0 Flow 50.0 Mom 60.0
CNVS NASDAQ
Cineverse Corp. Class A Common Stock
Services-Video Tape Rental
$1.73
-5.46% 1D
Market Cap $49.1M
1M Return +12.34%
1Y Return -32.42%
Forward P/E 38.8x
Unified AI Score
35.9 / 100 SELL
Tech 15.0 Fund 36.0 Flow 54.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABVC -68.15% CNVS -32.42% Spread: +35.73 pp (CNVS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABVC TTM Op. Margin: 0.0% CNVS TTM Op. Margin: -12.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVC vs CNVS. Trailing 12-month operating profitability (ABVC 0.0% vs CNVS -12.0%) and valuation multiples (ABVC N/M vs CNVS 38.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABVC (4) vs CNVS (6)
Institutional Metric ABVC CNVS Criterion Row Winner
Market Capitalization Scale $23.9M $49.1M Larger Scale CNVS
Trailing P/E Ratio Valuation N/M 38.8x Lower Multiple CNVS
Forward P/E Ratio Valuation N/M 38.8x Lower Multiple CNVS
Revenue Growth (YoY) Growth +104.5% +110.0% Higher Growth CNVS
Operating Margin (TTM) Profitability 0.0% -12.0% Higher Margin ABVC
Net Profit Margin Profitability 0.0% -2.1% Higher Margin ABVC
Return on Equity (ROE) Capital Efficiency -52.7% -4.6% Higher ROE CNVS
52-Week Range Position Momentum 7% ($1โ€“$3) 16% ($1โ€“$3) Stronger Trend CNVS
Beta / 30D Volatility Risk Regime 1.24ฮฒ ยท 44% Vol 1.19ฮฒ ยท 110% Vol Lower Realized Risk ABVC
Unified Institutional Score Composite Signal 47.4 / 100 (HOLD) 35.9 / 100 (SELL) Higher Composite ABVC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABVC vs CNVS Buy Guide
ABVC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ABVC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CNVS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 28th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CNVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABVC nor CNVS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.